| 1212 Duyvesteyn, HME, Tuekprakhon, A., Nutalai, R., et al.(2021). Evidence of escape of 1213 SARS-CoV-2 variant B. 1.351 from natural and vaccine-induced sera D Zhou, W Dejnirattisai, P Supasa, C Liu, AJ Mentzer, HM Ginn, Y Zhao Cell 184, 2348-1117, 0 | | |
| 315 Structural basis for the neutralization of SARS-CoV-2 by an antibody from a 316 convalescent patient D Zhou, HME Duyvesteyn, CP Chen, CG Huang, TH Chen, SR Shih bioRxiv, 2020 | | 2020 |
| A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses TK Tan, P Rijal, R Rahikainen, AH Keeble, L Schimanski, S Hussain, ... Nature communications 12 (1), 542, 2021 | 240 | 2021 |
| A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses. Nat Commun … TK Tan, P Rijal, R Rahikainen, AH Keeble, L Schimanski, S Hussain, ... Nature Publishing Group, 2021 | 12 | 2021 |
| A delicate balance between antibody evasion and ACE2 affinity for Omicron BA. 2.75 H Jiandong, A Dijokaite-Guraliuc, L Chang, Z Daming, HM Ginn, R Das, ... CELL REPORTS 42 (1), 2023 | | 2023 |
| A delicate balance between antibody evasion and ACE2 affinity for Omicron BA. 2.75 J Huo, A Dijokaite-Guraliuc, C Liu, D Zhou, HM Ginn, R Das, P Supasa, ... Cell Reports 42 (1), 2023 | 40 | 2023 |
| A monoclonal antibody targeting the Nipah virus fusion glycoprotein apex imparts protection from disease VA Avanzato, T Bushmaker, KY Oguntuyo, KC Yinda, HME Duyvesteyn, ... bioRxiv, 2022.09. 26.507980, 2022 | | 2022 |
| A structure-function analysis shows SARS-CoV-2 BA. 2.86 balances antibody escape and ACE2 affinity C Liu, D Zhou, A Dijokaite-Guraliuc, P Supasa, HME Duyvesteyn, ... Cell Reports Medicine, 2024 | 1 | 2024 |
| Accelerating drug target inhibitor discovery with a deep generative foundation model V Chenthamarakshan, SC Hoffman, CD Owen, P Lukacik, ... Science Advances 9 (25), eadg7865, 2023 | 15 | 2023 |
| Accelerating Inhibitor Discovery for Multiple SARS-CoV-2 Targets with a Single, Sequence-Guided Deep Generative Framework V Chenthamarakshan, S Hoffman, CD Owen, P Lukacik, ... | | 2022 |
| Accelerating Inhibitor Discovery With A Deep Generative Foundation Model: Validation for SARS-CoV-2 Drug Targets V Chenthamarakshan, SC Hoffman, CD Owen, P Lukacik, ... arXiv preprint arXiv:2204.09042, 2022 | | 2022 |
| Antibody escape of SARS-CoV-2 Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum A Tuekprakhon, R Nutalai, A Dijokaite-Guraliuc, D Zhou, HM Ginn, ... Cell 185 (14), 2422-2433. e13, 2022 | 593 | 2022 |
| Antibody evasion by the Brazilian P. 1 strain of SARS-CoV-2 (preprint) W Dejnirattisai, D Zhou, P Supasa, C Liu, AJ Mentzer, H Ginn, Y Zhao, ... | | 2021 |
| Antibody evasion by the Brazilian P. 1 strain of SARS-CoV-2. bioRxiv. 2021 W Dejnirattisai, D Zhou, P Supasa, C Liu, AJ Mentzer, HM Ginn, Y Zhao, ... https://www. biorxiv. org/content/10.1101/2021.03 12, v1, 0 | 4 | |
| Antibody evasion by the P. 1 strain of SARS-CoV-2 D Wanwisa, Z Daming, S Piyada, L Chang, JM Alexander, MG Helen Cell 184 (11), 2939-2954, 2021 | | 2021 |
| Antibody evasion by the P. 1 strain of SARS-CoV-2 W Dejnirattisai, D Zhou, P Supasa, C Liu, AJ Mentzer, HM Ginn, Y Zhao, ... Cell 184 (11), 2939-2954. e9, 2021 | 666 | 2021 |
| Antibody evasion by the P. 1 strain of SARS-CoV-2 W Dejnirattisai, D Zhou, P Supasa, C Liu, AJ Mentzer, HM Ginn, Y Zhao, ... Cell 184 (11), 2939-2954. e9, 2021 | 666 | 2021 |
| Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 J Huo, A Le Bas, RR Ruza, HME Duyvesteyn, H Mikolajek, T Malinauskas, ... Nature Structural & Molecular Biology 28 (3), 326, 2021 | 4 | 2021 |
| Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 J Huo, A Le Bas, RR Ruza, HME Duyvesteyn, H Mikolajek, T Malinauskas, ... Nature Structural & Molecular Biology 27 (11), 1094, 2020 | 6 | 2020 |
| Bacteriophage PRD1 as a nanoscaffold for drug loading HME Duyvesteyn, I Santos-Pérez, F Peccati, A Martinez-Castillo, ... Nanoscale 13 (47), 19875-19883, 2021 | 4 | 2021 |
